{
    "title": "A bill to amend the Controlled Substances Act to place synthetic drugs in Schedule I.",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Synthetic Drug Abuse Prevention Act \nof 2012''.\n\nSEC. 2. ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I OF THE CONTROLLED \n              SUBSTANCES ACT.\n\n    (a) Cannabimimetic Agents.--Schedule I, as set forth in section \n202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended \nby adding at the end the following:\n    ``(d)(1) Unless specifically exempted or unless listed in another \nschedule, any material, compound, mixture, or preparation which \ncontains any quantity of cannabimimetic agents, or which contains their \nsalts, isomers, and salts of isomers whenever the existence of such \nsalts, isomers, and salts of isomers is possible within the specific \nchemical designation.\n    ``(2) In paragraph (1):\n            ``(A) The term `cannabimimetic agents' means any substance \n        that is a cannabinoid receptor type 1 (CB1 receptor) agonist as \n        demonstrated by binding studies and functional assays within \n        any of the following structural classes:\n                    ``(i) 2-(3-hydroxycyclohexyl)phenol with \n                substitution at the 5-position of the phenolic ring by \n                alkyl or alkenyl, whether or not substituted on the \n                cyclohexyl ring to any extent.\n                    ``(ii) 3-(1-naphthoyl)indole or 3-(1-\n                naphthylmethane)indole by substitution at the nitrogen \n                atom of the indole ring, whether or not further \n                substituted on the indole ring to any extent, whether \n                or not substituted on the naphthoyl or naphthyl ring to \n                any extent.\n                    ``(iii) 3-(1-naphthoyl)pyrrole by substitution at \n                the nitrogen atom of the pyrrole ring, whether or not \n                further substituted in the pyrrole ring to any extent, \n                whether or not substituted on the naphthoyl ring to any \n                extent.\n                    ``(iv) 1-(1-naphthylmethylene)indene by \n                substitution of the 3-position of the indene ring, \n                whether or not further substituted in the indene ring \n                to any extent, whether or not substituted on the \n                naphthyl ring to any extent.\n                    ``(v) 3-phenylacetylindole or 3-benzoylindole by \n                substitution at the nitrogen atom of the indole ring, \n                whether or not further substituted in the indole ring \n                to any extent, whether or not substituted on the phenyl \n                ring to any extent.\n            ``(B) Such term includes--\n                    ``(i) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-\n                hydroxycyclohexyl]-phenol (CP-47,497);\n                    ``(ii) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-\n                hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-\n                47,497 C8-homolog);\n                    ``(iii) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and \n                AM678);\n                    ``(iv) 1-butyl-3-(1-naphthoyl)indole (JWH-073);\n                    ``(v) 1-hexyl-3-(1-naphthoyl)indole (JWH-019);\n                    ``(vi) 1-[2-(4-morpholinyl)ethyl]-3-(1-\n                naphthoyl)indole (JWH-200);\n                    ``(vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole \n                (JWH-250);\n                    ``(viii) 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole \n                (JWH-081);\n                    ``(ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole \n                (JWH-122);\n                    ``(x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-\n                398);\n                    ``(xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole \n                (AM2201);\n                    ``(xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole \n                (AM694);\n                    ``(xiii) 1-pentyl-3-[(4-methoxy)-benzoyl]indole \n                (SR-19 and RCS-4);\n                    ``(xiv) 1-cyclohexylethyl-3-(2-\n                methoxyphenylacetyl)indole (SR-18 and RCS-8); and\n                    ``(xv) 1-pentyl-3-(2-chlorophenylacetyl)indole \n                (JWH-203).''.\n    (b) Other Drugs.--Schedule I of section 202(c) of the Controlled \nSubstances Act (21 U.S.C. 812(c)) is amended in subsection (c) by \nadding at the end the following:\n            ``(18) 4-methylmethcathinone (Mephedrone).\n            ``(19) 3,4-methylenedioxypyrovalerone (MDPV).\n            ``(20) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).\n            ``(21) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).\n            ``(22) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).\n            ``(23) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).\n            ``(24) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-\n        T-2).\n            ``(25) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine \n        (2C-T-4).\n            ``(26) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).\n            ``(27) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).\n            ``(28) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-\n        P).''.\n\nSEC. 3. TEMPORARY SCHEDULING TO AVOID IMMINENT HAZARDS TO PUBLIC SAFETY \n              EXPANSION.\n\n    Section 201(h)(2) of the Controlled Substances Act (21 U.S.C. \n811(h)(2)) is amended--\n            (1) by striking ``one year'' and inserting ``2 years''; and\n            (2) by striking ``six months'' and inserting ``1 year''."
}